Table 2. Participants of the UK Biobank Included in This Studya.
| Study | UK Biobankb |
|---|---|
| Participants, No. | 452 302 |
| Sex, No. (%) | |
| Men | 206 951 (46) |
| Women | 245 351 (54) |
| Age at baseline, mean (SD), y | 57 (8) |
| Men | 57 (8) |
| Women | 57 (8) |
| Currently smoking, No. (%) | 47 036 (10) |
| Men | 25 165 (12) |
| Women | 21 867 (9) |
| Body mass index, mean (SD) [No. missing]c | 27.4 (4.8) [1594] |
| Men | 27.9 (4.2) |
| Women | 27.0 (5.1) |
| Waist-to-hip ratio, mean (SD) [No. missing] | 0.87 (0.09) [883] |
| Men | 0.94 (0.07) |
| Women | 0.82 (0.07) |
| Waist circumference, mean (SD) [No. missing], cm | 90 (13.5) [790] |
| Men | 97 (11.4) |
| Women | 85 (12.5) |
| Hip circumference, mean (SD) [No. missing], cm | 103 (9.2) [838] |
| Men | 104 (7.6) |
| Women | 103 (10.3) |
| Systolic blood pressure, mean (SD) [No. missing], mm Hg | 138 (19) [863] |
| Men | 141 (17) |
| Women | 135 (19) |
| Diastolic blood pressure, mean (SD) [No. missing], mm Hg | 82 (10) [850] |
| Men | 84 (10) |
| Women | 81 (10) |
a
The exact numbers of participants included in each genetic analysis are in eTable 1 in the Supplement.
b
Genotyping in the UK Biobank was performed using the Affymetrix UK BILEVE and UK Biobank Axiom arrays, with Haplotype Reference Consortium r1.1 as the imputational panel.
c
Calculated as weight in kilograms divided by height in meters squared.